Mar 262015
 March 26, 2015

medical marijuanaThe country’s leading medical marijuana advocacy group, Americans for Safe Access (ASA), will hold its third annual national Unity Conference, “Wellness is Winning,” in Washington, D.C. on March 27-31, 2015. The conference will highlight medical and legal experts, policymakers, and a wide array of workshops and panels focusing on scientific research, strategic planning, and skills building. On Tuesday, March 31st, ASA will host a press conference at 11am, followed by a lobby day with hundreds of patient advocates.

What: Third Annual National Unity Conference, “Wellness is Winning”
When: March 27-31, 2015, including a press conference at 11am on March 31st
Where: Loews Madison Hotel, 1177 15th Street NW, Washington, D.C., press conference will be on the Capitol grounds

Media is invited to attend the conference at no charge; participants are encouraged toregister in advance.

“Patients and advocates are excited to be gathering this year after an historic victory in Congress, which paved the way for a very promising bill in the US Senate,” said ASA Executive Director Steph Sherer. “Hundreds of patients and advocates will gather in the nation’s capitol next week with a unified goal to urge Congress to adopt sensible federal medical marijuana policy reform.”

The national conference comes just two weeks after a comprehensive medical marijuana bill was introduced in the US Senate, endorsed by several advocacy groups including ASA, which helped Senate authors develop the legislation. Senators Rand Paul (R-KY), Cory Booker (D-NJ), and Kirsten Gillibrand (D-NY) introduced S.683, the Compassionate Access, Research Expansion, and Respect States (CARERS) Act to end the federal prohibition on medical marijuana and allow states to set their own policies.

The conference also follows an historic vote in Congress with the adoption of Section 538 of the Appropriations Act, a one-year spending provision that prohibits the Department of Justice (DOJ) from using its funds to interfere in the implementation of state medical marijuana laws.

Notably, the first conference panel on Saturday, March 28th is “We are Winning!” which will feature medical marijuana experts in the field, followed by a panel on Congress and the CARERS Act, and the conference Key Note by cannabis researcher Ethan Russo, MD. That afternoon, experts on product safety will explore the current state of product safety laws and regulations as well as implications for patients and medical marijuana industries. The program will close on Saturday with stakeholder break-out sessions to discuss issues affecting medical marijuana patients, medical professionals and researchers, the cannabis industry, veterans, and the parents of pediatric patients.

Sunday, March 29th will begin with a panel on overcoming persistent and pervasive stigma related to employment, housing, parental rights, and access to health care. The panel will address the roots of this discrimination and solutions for overcoming it on a personal and political level. Medical marijuana researchers will then discuss exciting new developments and clinical applications of cannabis, which will be followed by a panel on harmonizing the regulatory schemes of different cannabis sectors from legalization to pharmaceuticalization, and from herbal medicine to industrial hemp.

Monday, March 30th will be dedicated to skills building and education for activists, including workshops on advocating for cannabis as a medicine, social media training, best practices for nurses and caregivers, utilizing local voter initiatives, building relationships with elected officials, parenting and medical marijuana, as well as developing and supporting legislation and regulations. There will also be three educational programs Monday for medical professionals and industry stakeholders, as well as a detailed analysis of the cannabis plant. Monday evening, ASA will host its awards banquet, which recognizes individuals who have made extraordinary contributions to the promotion and expansion of safe access to medical marijuana.

Tuesday, March 31st will begin with a press conference on the Capitol grounds, featuring Members of Congress, patient advocates and experts in the field. The press conference will be followed by a grassroots lobbying effort in which hundreds of patient advocates will urge their Senators to adopt sensible federal medical marijuana policy by voting for the CARERS Act.

Sponsors of the conference include OrganiCann, the Society of Cannabis Clinicians, Grace, Mary’s Medicinals, CannaBest Medical, Abattis Bioceuticals, Remedy Compassion Center, and the American Herbal Products Association.

Further information:
Third Annual National Medical Cannabis Unity Conference:http://www.nationalmedicalcannabisunityconference.org/
Media registration: http://www.nationalmedicalcannabisunityconference.org/request_unity_press_pass

Source: Americans for Safe Accessmake a donation

Comments

comments

About Johnny Green

Dissenting opinions are welcome, insults and personal attacks are discouraged and hate speech will not be tolerated. Spammers and people trying to buy or sell cannabis or any drugs will be banned. Read our comment policy and FAQ for more information

  2 Responses to “Medical Marijuana Advocacy Group To host Third Annual National Conference In DC”

  1.  

    I will be attending this event with 6 other Veterans from across the country, who have suffered from PTSD and benefited from cannabis use. We’re attending at the request of Dr Sue Sisley, who will be a featured Speaker on Saturday. She’s got some new information on her studies. She just arrived back from Israel where THEY want to perform her study on Israeli veterans. Just like she WANTS to do here in the States. She STILL wants to perform her study in the States. But this way we’ll at least have some data to put more pressure on the Govt to allow cannabis research in the U.S.

    We’re lobbying Congress Tuesday to have them remove the barriers to cannabis research. Cannabis is the ONLY Schedule I drug that has to get approval from NIDA (the VERY agency who’s stifled cannabis research for years) in order to obtain any Federal cannabis to study. Heroin, Methamphetamines, LSD, etc… AREN’T even required to get that approval in order to study ANY of them! Something SO benign yet SO restricted?

    Please call your Federal Representatives and tell them to REMOVE the barriers to cannabis research. It’s time we settle this argument once and for all. Is it medicine or not? What are they afraid of? What are they hiding?

    I myself am not really supportive of the CARERS Act. I don’t believe it goes far enough. I believe moving it to Schedule II, only ensures that Big Pharma is in control of the product. That way they can produce their Cannabis Sprays, Pills, Salves and Ointments. Then claim THEY discovered this miracle drug and charge you exorbitant amounts of money to obtain their drug. All the time the RAW PLANT well be illegal for you and I.

  2.  

    Soooo wish I could attend this event. I am going to PLAN on it next year.

 Leave a Reply